1910 Genetics is a company that develops a small molecule drug discovery engine. It offers SUEDE, a virtual screening platform, which screens molecules to identify compounds; BAGEL, a generative chemistry platform that generates molecules using a compound as a template; and CANDID, a physical property prediction platform for multi-parameter optimization. The company caters to biopharma, educational, and government sectors.